EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Yoga-Based Group Intervention for Inpatients with Schizophrenia Spectrum Disorders—Feasibility, Acceptability, and Preliminary Outcomes of a Rater-Blinded Randomized Controlled Trial

Inge Hahne iD, Marco Zierhut iD, Niklas Bergmann iD, Eric Hahn, Thi Minh Tam Ta, Claudia Calvano iD, Malek Bajbouj, Kerem Böge

Schizophrenia Bulletin · 2026

DOI: 10.1093/schbul/sbae198 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Schizophrenia Bulletin, 2026. Verfasst von Inge Hahne und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neuroscience, Campus Benjamin Franklin, Charité -Universitätsmedizin Berlin, 12203, Berlin, Germany. Hauptthemen laut MEDLINE: Yoga, Schizophrenia, Psychotherapy, Group, Outcome Assessment, Health Care. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Charité - Universitätsmedizin Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis The efficacy of yoga as an adjunctive treatment for schizophrenia spectrum disorders (SSD) has garnered interest. While yoga may positively influence various symptom domains, further investigation is needed due to the limited number, quality, and generalizability of studies. This study assessed the feasibility and acceptability (primary outcome) of a yoga-based group intervention (YoGI) developed in a participatory approach and explored its preliminary effectiveness. Study Design In addition to the primary outcomes, this preregistered randomized controlled trial examined rater-blinded general psychopathology, positive- and negative symptoms, and self-rated depression, anxiety, stress, body mindfulness, mindfulness, psychological flexibility, cognition, social functioning, quality of life, and medication regime at baseline and postintervention as secondary outcomes. Study Results Fifty inpatients with SSD received either TAU (n = 25) or YoGI + TAU (n = 25) for four weeks. Outcomes showed 95% protocol adherence of YoGI, feasibility, and retention rates of 91% and 94%, respectively, and a dropout rate of 6%. ANCOVA revealed significant between-group postintervention improvements for YoGI + TAU in positive symptoms, depression, cognitive fusion, and a mindfulness subscale. Medium-to-large pre- to postintervention effects were found for body mindfulness, positive, negative, and general psychopathology, cognitive fusion, depression, anxiety, stress, quality of life, and attention in YoGI + TAU, while within-group changes were consistently smaller in TAU. No severe adverse events were reported. Conclusions This trial supports the feasibility and acceptability of YoGI for inpatients with SSD and provides preliminary evidence of YoGI’s benefits beyond TAU. Further robust, multicentric RCTs are warranted to deepen our understanding of YoGI’s therapeutic potential and inform clinical interventions for SSD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

YogaSchizophreniaPsychotherapy, GroupOutcome Assessment, Health CarePatient Acceptance of Health CarePsychotic DisordersHumansMaleFemaleAdultMiddle AgedFeasibility StudiesSingle-Blind MethodMindfulnessInpatients

Stichwörter der Autor:innen

body mindfulnessmindfulnessphysical exercisepsychosispsychotic disorders

Autor:innen und Institutionen

  • Department of Psychiatry and Neuroscience, Campus Benjamin Franklin, Charité -Universitätsmedizin Berlin, 12203, Berlin, Germany.
  • Department of Education and Psychology, Clinical Child and Adolescent Psychology and Psychotherapy, Freie Universität Berlin, 14195, Berlin, Germany.
  • German Center of Mental Health (DZPG), 10117, Berlin, Germany.
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité (Junior) (Digital) Clinician Scientist Program, 10117, Berlin, Germany.
  • Department of Psychology, Medical University Brandenburg, 16816, Neuruppin, Germany.

ORCID-Profile: Inge Hahne, Marco Zierhut, Niklas Bergmann, Claudia Calvano

Förderung

  • Charité - Universitätsmedizin Berlin

Zitieren

APA

Hahne, I., Zierhut, M., Bergmann, N., Hahn, E., Ta, T. M. T., Calvano, C., Bajbouj, M., & Böge, K. (2026). Yoga-Based Group Intervention for Inpatients with Schizophrenia Spectrum Disorders—Feasibility, Acceptability, and Preliminary Outcomes of a Rater-Blinded Randomized Controlled Trial. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbae198

Vancouver

Hahne I, Zierhut M, Bergmann N, Hahn E, Ta TMT, Calvano C, et al. Yoga-Based Group Intervention for Inpatients with Schizophrenia Spectrum Disorders—Feasibility, Acceptability, and Preliminary Outcomes of a Rater-Blinded Randomized Controlled Trial. Schizophrenia Bulletin. 2026. doi:10.1093/schbul/sbae198

BibTeX
@article{Hahne2026,
  author = {Hahne, Inge and Zierhut, Marco and Bergmann, Niklas and Hahn, Eric and Ta, Thi Minh Tam and Calvano, Claudia and Bajbouj, Malek and Böge, Kerem},
  title = {Yoga-Based Group Intervention for Inpatients with Schizophrenia Spectrum Disorders—Feasibility, Acceptability, and Preliminary Outcomes of a Rater-Blinded Randomized Controlled Trial},
  journal = {Schizophrenia Bulletin},
  year = {2026},
  doi = {10.1093/schbul/sbae198}
}
Kostenlos starten →